Enjoy complimentary customisation on priority with our Enterprise License!
The number of women dying due to complications associated with pregnancy and childbirth is increasing rapidly globally. Also, women suffering from complications that result in long-lasting sequelae often succumb to maternal death. Complications due to pregnancy such as multiple births, preterm births, and macrosomia increases the risk of PPH. Technavio’s market study identifies the increasing complications and risk factors for PPH to be one of the primary growth factors for the postpartum hemorrhage (PPH) devices market. Risky factor such as uterine atony, trauma, retained placenta, obesity, and bleeding disorders also drive the rising incidences of PPH. Trauma is the leading non-obstetric cause of death whereas uterine atony is the most common cause of severe PPH within 24 hours. According to postpartum hemorrhage devices market forecast, our analysts estimate that the market will grow steadily at a CAGR of more than 5% by 2022.
The increasing focus on the development of low-cost PPH treatment devices is one of the key factors driving the growth of the postpartum hemorrhage devices market size. Hospitals primarily administer uterine balloon tamponade to cure PPH. However, due to the exponentially high cost and single usage, hospitals are sourcing for low-cost alternative PPH treatment devices. Manufacturers are increasingly offering low-cost postpartum hemorrhage treatment devices to drive their adoption and accessibility globally, primarily in developing and low-resource countries.
The postpartum hemorrhage (PPH) devices market is fragmented owing to the presence of several international and regional numerous vendors. This market report includes information about key companies and their product portfolio. This report also focuses on the competitive environment between the players in the postpartum bleeding market. Technavio’s analysts also analyze the strategies adopted by vendors and the competitive analysis of the postpartum hemorrhage (PPH) devices market.
Our market research analysts identify some of the key companies in the postpartum hemorrhage (PPH) devices market
The uterine balloon tamponade product segment will account for the major share in the postpartum bleeding market throughout the forecast period. However, it is witnessed that this industry segment experiences a steady growth.
The Americas will be the major revenue contributor to the PPH market throughout the forecast period. Factors such as high incidence of PPH, high hospital delivery rate, increase in medical complications related to pregnancy, high awareness among end-users about advanced PPH treatments, advanced healthcare infrastructure, and the increased healthcare expenditure will drive the growth of the postpartum bleeding market in this region.
Technavio also offers customization on reports based on specific client requirement.
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
PART 05: MARKET SIZING
PART 06: FIVE FORCES ANALYSIS
PART 07: MARKET SEGMENTATION BY PRODUCT
PART 08: CUSTOMER LANDSCAPE
PART 09: REGIONAL LANDSCAPE
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
PART 12: MARKET TRENDS
PART 13: VENDOR LANDSCAPE
PART 14: VENDOR ANALYSIS
PART 15: APPENDIX
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.